RE4 IS MARKET ACCESS FOR ONCOLOGY TREATMENTS EASIER IN ENGLAND THAN FOR NON-ONCOLOGY TREATMENTS? AN ANALYSIS OF NICE SINGLE TECHNOLOGY APPRAISALS FROM 2017-2019
Abstract
Authors
F. Chunara C. Wilson G. Foxon P. Craddy
F. Chunara C. Wilson G. Foxon P. Craddy
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now